Stem cell life science products and services
Definigen has raised €2.8M across 1 funding round from 2 investors, most recently a Series A round in Jun 2014. Based in Cambridge, UK; founded 2012; active in Healthtech. Data as of 7 Aug 2026.
Timing: dormant vs cohort gap · momentum unknown. Funding-only estimates, not predictions and not investment advice — see signals.
| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2014-06-01 | Series A | €2.8M |
| 24Haymarket,London Business Angels (Angel Capital Group) |
| View deal → |
